Private healthcare keeps growing in 2026 for three connected reasons: an NHS waiting list of 7.3 million treatments with a median wait of 12.4 weeks, a self-pay market where people fund one-off procedures like a £2,000–£4,000 cataract directly, and employers adding health cover to compete for staff. The open question is whether private capacity can keep pace.
- ✓The NHS list stands at 7.3 million treatments; 1 in 12 waits 38.6+ weeks.
- ✓Self-pay lets people buy one procedure — from £300 MRIs to £15,000 hips — without a policy.
- ✓Around 31.5% of employers now offer health cover, and it's the most-valued voluntary benefit.
The engine: waiting that people can see and feel
NHS England's May 2026 referral-to-treatment release shows 7.3 million treatments waiting, with a median wait of 12.4 weeks and 1 in 12 patients waiting 38.6 weeks or more. Over 105,000 people have waited more than a year. In diagnostics, roughly 1 in 4 people wait six weeks or longer for a test.
The NHS is brilliant. The waiting isn't. And waiting is no longer an abstraction: most people now know someone who has waited months for a knee, a scan or a gynaecology appointment. That lived experience — more than any advert — is what pushes people to look at private options, whether that's insurance or paying for a single procedure.
The self-pay boom: buying one procedure, not a policy
The fastest-changing corner of the market is self-pay: people with no insurance paying directly for a single treatment. It suits people who face one specific wait and can find the money once, rather than committing to a monthly premium. Typical self-pay prices in 2026:
| Procedure | Typical self-pay price |
|---|---|
| Private MRI scan | £300–£500 |
| Cataract surgery (per eye) | £2,000–£4,000 |
| Inguinal hernia repair | £2,500–£4,500 |
| Hip replacement | £12,000–£15,500 |
| Knee replacement | £13,000–£16,000 |
Self-pay growth matters for insurance buyers too: it signals that demand for private treatment is broader than the insured population, and it's one reason self-pay versus insurance has become a genuine either-or decision for many households.
Employers: the quiet second engine
Around 31.5% of UK employers now offer health cover, and it consistently ranks as the most-valued voluntary benefit. The employer case is partly recruitment and retention, partly arithmetic: sickness absence runs at 9.4 days per employee per year, and absence costs UK employers an estimated £103bn annually. Group cover typically runs £35–£110 per employee per month — often 10–30% cheaper per head than equivalent personal cover.
Corporate demand also changes who is covered. Group schemes routinely use medical history disregarded underwriting, bringing in employees whose pre-existing conditions would be excluded on a personal policy. As more mid-sized firms add schemes, a growing share of the privately covered population got there through work rather than through a personal decision. That matters for the market's future too: employees who experience private care through a job often keep some form of cover when they move on, seeding demand that outlasts any single scheme.
The 2027 payrolling change — which moves benefit-in-kind reporting from P11D forms into payroll — will make the cost of workplace health cover more visible to employees on their payslips. How that visibility affects uptake is one of the more interesting open questions for the employer market.
See what private cover would cost you
The capacity question nobody has fully answered
Growth on the demand side raises an obvious question: can supply keep up? Private hospitals draw consultants largely from the same pool as the NHS, and independent-sector capacity is also used by the NHS itself to work through its backlog. If demand keeps rising faster than theatres, beds and consultant hours, the private sector's core promise — a consultation typically within days, routine surgery in 2–6 weeks — comes under pressure in the busiest specialties and regions.
For now, the direction of travel is clear: as long as NHS recovery is gradual, demand for private options — insured, self-pay and employer-funded — keeps growing. Whether it's worth it for you depends on your age, health and how much the prospect of a 12-week-plus wait worries you.
Frequently asked questions
Why is private healthcare growing so fast in 2026?
Three drivers: an NHS waiting list of 7.3 million treatments with a 12.4-week median wait, a self-pay market that lets people fund single procedures directly, and employers adding health cover to attract and keep staff. Each reinforces the others, and none looks likely to reverse quickly.
Is the private healthcare market growing mainly through insurance or self-pay?
Both, but self-pay is the fastest-changing part. Self-pay suits a one-off need — a £300–£500 MRI or a £12,000–£15,500 hip — while insurance covers the unknown. Employer-funded group schemes are the third engine, now offered by around 31.5% of UK employers.
Can private hospitals cope with the growth in demand in 2026?
It's the market's open question. Private hospitals share much of their consultant workforce with the NHS, and the NHS also buys independent-sector capacity for its own backlog. Private treatment remains much faster — consultations typically within days — but in the busiest specialties, private waits can lengthen too.
Will NHS waiting lists coming down stop private healthcare growing?
A sustained fall in waits would ease the main driver, but recovery has been gradual — the list still stands at 7.3 million with 105,000+ people waiting over a year. Employer demand and the habit of self-paying for speed are unlikely to vanish even if headline waits improve.